Pepinemab Program Overview News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Pepinemab Program Overview. Real-time updates on events, politics, business and more.

Vaccinex Reports Second Quarter 2022 Results and Provides

August 15, 2022

Promising initial responses in continuing Phase 1b/2 KEYNOTE B84 study of pepinemab with KEYTRUDA® in Recurrent/Metastatic Head and Neck Squamous Cell...

United States United Kingdom John Mullaly Maurice Zauderer Alzheimer Association International Conference Merck Co

Source: globenewswire.com

Vaccinex Reports Second Quarter 2022 Results and Provides Corporate Update; Excellent Progress in Pepinemab Clinical Programs

August 15, 2022

15.08.2022 - Promising initial responses in continuing Phase 1b/2 KEYNOTE B84 study of pepinemab with KEYTRUDA in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Phase 2 SIGNAL-HD Study Published in Nature Medicine Patient enrollment continues in ...

United States United Kingdom John Mullaly Maurice Zauderer Alzheimer Association International Conference Merck Co

Source: wallstreet-online.de

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Pepinemab Program Overview News Today

Vaccinex Reports Second Quarter 2022 Results and Provides

Vaccinex Reports Second Quarter 2022 Results and Provides Corporate Update; Excellent Progress in Pepinemab Clinical Programs

Explore More Categories